Palantir's Contract Machine Grinds On — But the Signals Are Getting Harder to Read

Palantir's record backlog and surging revenue contrast with CEO's $86M stock sale and analyst valuation concerns.

There is a peculiar tension at the heart of Palantir's current market narrative. The company is signing contracts at a pace that would make most defense contractors blush, its backlog has never been fatter, and the stock has been on a tear that has caught the attention of even casual market watchers. Yet the chief executive just sold nearly $86 million worth of shares, and a chorus of analysts can't seem to agree on whether the equity is a screaming buy or a stretched one.

That contradiction is worth unpacking, because it says more about where Palantir stands today than any single headline number.

Start with the deal flow, which has been relentless. On August 25, Palantir and Raytheon jointly secured a contract ceiling of $876 million for the US Army's Distributed Common Ground System. The same day, the company reported a record remaining performance obligation of $13.1 billion for the second quarter of 2026 — a figure that landed alongside media reports of a potential $875 million contract loss, apparently tied to the FAA. The juxtaposition is instructive: Palantir is losing business, yes, but it is replacing it with ease.

The bigger prize, however, is Maven. The US Army expanded the Maven Smart System contract to as much as $1.3 billion over five years, and William Blair analyst Louie DiPalma has pegged the program's potential at up to $1 billion in annual recurring revenue. By the end of September, Maven is expected to achieve "Program of Record" status — the bureaucratic milestone that transforms a pilot into a permanent fixture of the armed forces. Government contracts already account for roughly 42 percent of quarterly revenue, which means anyone buying Palantir stock is, in essence, betting on the deepening fusion of military and commercial AI software.

That fusion now extends well beyond the Pentagon. Josh Harris, owner of the Philadelphia 76ers, uses Palantir technology for high-frequency trading — a reminder that the company's analytics platform has moved into arenas with no connection to national security. On August 28, Palantir announced partnerships with Mercury Systems, integrating AI software into supply chain and manufacturing processes for US military programs, and with Snowflake, linking Palantir Foundry and AIP to the Snowflake AI Data Cloud for enterprise-scale applications. Both read as deliberate attempts to diversify beyond the defense sector.

The commercial push is backed by numbers that are hard to argue with. Second-quarter revenue hit $1.94 billion, up 93 percent year over year. US government business climbed 90 percent to $809 million, while US commercial revenue surged 149 percent to $764 million. The company raised its full-year guidance to between $8.15 billion and $8.16 billion.

Wall Street has responded in kind. Baird's William Power reaffirmed his Outperform rating and $200 price target after a tech demo, Citigroup sits at $245, UBS lifted its target to $220 in late August, and Bank of America is reportedly at $255. Simply Wall St noted on August 26 that the consensus price target had been raised from $182 to $192, supported by a 12 percent increase in fiscal 2026 earnings estimates.

Not everyone is convinced. Seeking Alpha analyst Juxtaposed Ideas downgraded the stock from Buy to Hold on August 18, citing an overextended valuation following the post-earnings rally. That caution is worth weighing against the optimists: even those who believe in the operational momentum have to acknowledge the price the market is already asking.

Then there are the insider sales. CEO Alexander Karp disposed of roughly 492,000 shares on August 20 at an average price of $174.79, totaling about $86 million, according to a mandatory filing under a Rule 10b5-1 plan to cover tax obligations. Such automated plans are legally clean and common for executives with large equity stakes. Still, there is an unavoidable aftertaste when the chief executive cashes out amid euphoric price targets.

The stock itself reflects this split personality. After a 47 percent gain in 30 days, shares trade about 11 percent below their 52-week high of $179.98, with an annualized volatility of 99 percent. The RSI sits at 68.9 — a level that suggests buying momentum is getting sporty, if not outright overheated. The primary article cites an RSI of 67.6, a minor discrepancy between sources that does little to change the technical picture.

The ethical and political dimensions are never far from the surface. Reports indicate that US immigration authorities improperly shared Medicaid data with Palantir, whose ELITE application is used to track non-citizens. Democratic state attorneys general sued; a judge permitted partial data sharing, and the agency could not guarantee that all copies of the data had been deleted. On August 27, members of National Nurses United protested in eight US cities against the company's health and government contracts, citing privacy and ethics concerns.

None of this has slowed the stock, and it probably won't. The debate over what role data analytics firms should play in democracies is not going away as long as agencies like ICE rely on such tools. But for investors, the question is simpler: is Palantir a software company, or a bet on the future of state surveillance? For analysts with targets ranging from $200 to $255, the answer appears to be that growth trumps concern.

The more immediate question is whether the stock has gotten ahead of itself. The operational arguments are real — the defense pipeline and commercial partnerships are growing, and the backlog is at a record. But stretched valuation, insider selling, and a rally that has already covered substantial ground suggest the easy money may have been made. Palantir's fundamentals and its share price are, for the moment, telling two different stories. Investors would do well to keep them separate.